These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 592869)

  • 21. Protective immunity in helminth diseases.
    Ogilvie BM; Jones VE
    Proc R Soc Med; 1969 Mar; 62(3):298-301. PubMed ID: 4976680
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary and secondary immunologic response].
    Halasa J
    Postepy Hig Med Dosw; 1970; 24(6):851-99. PubMed ID: 5491471
    [No Abstract]   [Full Text] [Related]  

  • 23. The time of onset of placental susceptibility in mice to heterologous anti-mouse placental serum.
    Kometani K; Behrman SJ
    Int J Fertil; 1971; 16(3):139-43. PubMed ID: 4331593
    [No Abstract]   [Full Text] [Related]  

  • 24. Clonal dominance and the preservation of clonal memory cells mediated by antigen-antibody.
    Askonas BA; McMichael AJ; Roux ME
    Immunology; 1976 Oct; 31(4):541-51. PubMed ID: 1086284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive drugs.
    Makinodan T; Santos GW; Quinn RP
    Pharmacol Rev; 1970 Jun; 22(2):189-247. PubMed ID: 4914001
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong-1-68 influenza viruses. 3. Immunodiffusion study of the antibody response.
    Styk B; Blaskovic D; Sabó A; Hána L; Kapitáncik B; Kaplan M
    Acta Virol; 1970 Jan; 14(1):35-46. PubMed ID: 4392075
    [No Abstract]   [Full Text] [Related]  

  • 27. The nature of the immune state produced by inactivated vaccinia virus in rabbits.
    Boulter EA; Zwartouw HT; Titmuss DH; Maber HB
    Am J Epidemiol; 1971 Dec; 94(6):612-20. PubMed ID: 4332354
    [No Abstract]   [Full Text] [Related]  

  • 28. Manipulation of the immune response.
    Siskind GW
    Pharmacol Rev; 1973 Jun; 25(2):319-24. PubMed ID: 4593206
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppressive therapy using cytostatics].
    Schumacher K; Ricken D
    Internist (Berl); 1971; 12():Suppl 1:142-8. PubMed ID: 4944100
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells.
    Greaves MF; Möller E; Möller G
    Cell Immunol; 1970 Oct; 1(4):386-403. PubMed ID: 4943359
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carrier state with pathogenic bacteria].
    Petersen KF
    MMW Munch Med Wochenschr; 1979 Feb; 121(5):177-8. PubMed ID: 105277
    [No Abstract]   [Full Text] [Related]  

  • 32. Defense mechanisms against infectious diseases: general considerations with particular reference to morphological and cellular aspects.
    Hess MW; Keller HU; Schädeli J; Schaffner T; Cottier H
    Monogr Allergy; 1975; 9():1-12. PubMed ID: 47142
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification of fetal immune system by maternal anti-DNA antibody. I. Enhanced immune response to DNA in the mice exposed to anti-DNA antibody early in life.
    Sasaki T; Ono Y; Ishida N
    J Immunol; 1977 Jul; 119(1):26-30. PubMed ID: 874321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological factors altering antibody synthesis].
    Halpern B
    Presse Med (1893); 1969 Mar; 77(15):539-42. PubMed ID: 4181928
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutralization of airway effects on bradykinin by antibodies.
    Davis TR; Goodfriend TL
    Am J Physiol; 1969 Jul; 217(1):73-7. PubMed ID: 5785903
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigenic competition between heterologous erythrocytes. II. Effect of passive antibody administration.
    Gershon RK; Kondo K
    J Immunol; 1971 Jun; 106(6):1532-9. PubMed ID: 4253531
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathogenesis of bacterial carrier state].
    Tychinin VA
    Vrach Delo; 1973 Jun; 6():138-43. PubMed ID: 4755116
    [No Abstract]   [Full Text] [Related]  

  • 38. The kinetics of hemolytic plaque formation.
    De Lisi CP; Bell GI
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):16-20. PubMed ID: 4589890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The formalinization of antibody to tumor cells in altering the immune response.
    Ungaro PC; Drake WP; Mardiney MR
    Cancer Res; 1972 Oct; 32(10):2241-7. PubMed ID: 4117036
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective immunosuppression using antigens and antibodies as pharmacologic agents.
    Siskind GW
    Fed Proc; 1974 Aug; 33(8):1886-8. PubMed ID: 4135738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.